当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 现金流量表

艾迪药业

(688488)

  

流通市值:64.55亿  总市值:64.55亿
流通股本:4.21亿   总股本:4.21亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金361,414,067.4184,943,492.27697,381,262.66511,289,444.93
  收到的税费返还2,170,431.31---
  收到其他与经营活动有关的现金57,037,192.0224,806,383.24166,817,841.86111,673,725.51
  经营活动现金流入小计420,621,690.73209,749,875.51864,199,104.52622,963,170.44
  购买商品、接受劳务支付的现金81,250,610.3149,322,261.59137,909,145.87103,839,174.84
  支付给职工以及为职工支付的现金88,650,132.3550,243,699.61142,434,709.29112,839,403.31
  支付的各项税费51,758,926.1629,778,225.23100,187,234.273,843,852.83
  支付其他与经营活动有关的现金173,901,871.0779,511,844.26466,036,514.39304,951,912.33
  经营活动现金流出小计395,561,539.89208,856,030.69846,567,603.75595,474,343.31
  经营活动产生的现金流量净额25,060,150.84893,844.8217,631,500.7727,488,827.13
二、投资活动产生的现金流量:
  取得投资收益收到的现金509,980.44382,220.951,510,922.151,221,649.87
  处置固定资产、无形资产和其他长期资产收回的现金净额--4,084,860.43119,850
  收到的其他与投资活动有关的现金110,000,00080,000,000391,000,000314,400,000
  投资活动现金流入小计110,509,980.4480,382,220.95396,595,782.58315,741,499.87
  购建固定资产、无形资产和其他长期资产支付的现金26,727,661.677,834,953.9847,934,622.8418,405,450.04
  投资支付的现金--5,250,0001,750,000
  取得子公司及其他营业单位支付的现金5,040,000-5,040,0005,040,000
  支付其他与投资活动有关的现金120,000,00030,000,000365,000,000285,000,000
  投资活动现金流出小计151,767,661.6737,834,953.98423,224,622.84310,195,450.04
  投资活动产生的现金流量净额-41,257,681.2342,547,266.97-26,628,840.265,546,049.83
三、筹资活动产生的现金流量:
  取得借款收到的现金496,924,000328,380,000477,924,000371,924,000
  筹资活动现金流入小计496,924,000328,380,000477,924,000371,924,000
  偿还债务支付的现金311,528,000172,228,000404,656,000373,706,000
  分配股利、利润或偿付利息支付的现金13,381,129.884,079,228.1320,871,234.5316,549,784.04
  支付其他与筹资活动有关的现金132,048,099.7270,452,665.142,358,778.61,896,009.49
  筹资活动现金流出小计456,957,229.6246,759,893.27427,886,013.13392,151,793.53
  筹资活动产生的现金流量净额39,966,770.481,620,106.7350,037,986.87-20,227,793.53
四、汇率变动对现金及现金等价物的影响-164,972.9-71,035.3-101,064.52-47,703.57
五、现金及现金等价物净增加额23,604,267.11124,990,183.2240,939,582.8612,759,379.86
  加:期初现金及现金等价物余额365,199,115.63365,199,115.63324,259,532.77324,259,532.77
  期末现金及现金等价物余额388,803,382.74490,189,298.85365,199,115.63337,018,912.63
补充资料:
  净利润32,170,963.33-8,083,067.42-
  资产减值准备140,834.7-17,011,257.89-
  固定资产和投资性房地产折旧16,406,099.39-33,489,540.73-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧16,406,099.39-33,489,540.73-
  无形资产摊销10,785,093.48-19,307,775.33-
  长期待摊费用摊销3,019,422.06-5,163,806.31-
  处置固定资产、无形资产和其他长期资产的损失-1,350,583.61--81,281.88-
  固定资产报废损失26,143.71-169,273.7-
  公允价值变动损失3,820,158.49--18,221,056.17-
  财务费用8,570,351.83-15,620,774.14-
  投资损失356,371.06-736,346.86-
  递延所得税1,739,859.23-1,697,912.4-
  其中:递延所得税资产减少2,188,921.99-128,601.58-
    递延所得税负债增加-449,062.76-1,569,310.82-
  存货的减少-12,756,337.43--21,531,059.96-
  经营性应收项目的减少-20,458,869.19--24,117,918.85-
  经营性应付项目的增加-23,938,291.98--26,220,010.77-
  其他4,360,929.59-3,706,401.78-
  现金的期末余额388,803,382.74-365,199,115.63-
  减:现金的期初余额365,199,115.63-324,259,532.77-
  现金及现金等价物的净增加额23,604,267.11-40,939,582.86-
公告日期2026-08-292026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑